efficiently hydrolyzed the cephalosporin: YOU-1 with a pl of 5 .57 and YOU-2 with a pl of 5.2. Genes encoding these enzymes were present on different but closely related high-molecular-weight, multiple antibiotic resistance plasmids of the HI2 incompatibility group and were transferable by conjugation in vitro. Agarose gel electrophoresis of extracts from clinical isolates indicated that this outbreak arose from plasmid transmission among different strains of the family Enterobacteriaceae rather than from dissemination of a single resistant isolate. Isolation rates of ceftazidime-resistant organisms transiently decreased after use of this drug was restricted, but resistant isolates continued to be recovered 7 months after empiric use of ceftazidime ceased.
The introduction of expanded-spectrum cephalosporins has facilitated safe and effective treatment of serious infections caused by enteric gram-negative bacilli. Unfortunately, increasing use of these agents has been associated with emergence of resistant bacterial strains. This resistance can be mediated by diminished outer membrane permeability, hyperproduction of chromosomal P-lactamase, acquisition of plasmid-mediated P-lactamases, or combinations of these mechanisms (1, 9, 17) . The extended-spectrum cephalosporin ceftazidime has gained wide popularity from its substantial activity against most members of the family Enterobacteriaceae as well as Pseudomonas aeruginosa. Although ceftazidime is remarkably resistant to the activities of most ,-lactamases, its use has recently been associated with the isolation of strains which elaborate plasmid-mediated enzymes with a high degree of activity against this agent (4, 13) . Originally described in Europe and cultured primarily from patients hospitalized in intensive care units, occasional strains have recently been encountered in the United States as well (8, 16, 19, 27) . We describe the hospital-wide dissemination of Enterobacteriaceae with plasmid-mediated ceftazidime resistance in a Massachusetts chronic-care facility and demonstrate that resistance in these isolates resulted from production of novel extended-spectrum ,B-lactamases. To the best of our knowledge, this represents the initial description of widespread dissemination of such strains within a hospital in the United States. 16 to 32 ,ug/ml) to ceftazidime were identified and saved, except during a 5-week period during which isolates were not available. When the isolates were available, organisms were included in the study if ceftazidime susceptibility was restored by the ,-lactamase inhibitor sulbactam (3) . If the isolate was not available, the patient was included only if, in addition to resistance to ceftazidime, resistance to chloramphenicol, gentamicin, and tetracycline was present, since this pattern was common to all but one of the available isolates and cotransferred with ceftazidime resistance.
MATERIALS
Criteria for infection. Clinical data were obtained by review of patient records, including clinical and laboratory results pertinent to the diagnosis of infection (peripheral leukocyte count, urinalysis, chest X ray), prior antibiotic treatment, and clinical and microbiologic responses to treatment. Infection was defined as either isolation of a ceftazidime-resistant organism from a normally sterile body site or isolation from a nonsterile body site, in the absence of other possible pathogens, and two of the following three clinical criteria: (i) fever, (ii) leukocyte count of .10,000/mm3, or (iii) evidence of local inflammation by physical or laboratory examination (i.e., infiltrate on chest radiography, leukocytes present on microscopic fluid analysis). Colonization was defined as isolation of an organism from a nonsterile body site in the absence of at least two of the signs of infection given above.
Among the patients judged to be infected, clinical response was defined as resolution of the signs of infection given above with appropriate therapy. Microbiologic response in patients for whom follow-up culture data were available was defined as the absence of the offending patho- (15) . Transconjugants were selected on glucose minimal medium (15) agar plates containing 10 ,ug of ceftazidime per ml, 30 ,ug of methionine per ml, 50 ,ug of proline per ml, and 100 ,ig of rifampin per ml for counterselection.
,-Lactamase characterization. Bacterial extracts were prepared by sonication, and ,B-lactamase was identified with the chromogenic substrate nitrocefin after analytical isoelectric focusing on a polyacrylamide gel (24) , except that the gel contained 1.7 ml of Ampholine at pH 3.5 to 10.0 and 1.5 ml of Ampholine at pH 4.0 to 6.0.
An inhibitor profile was determined by a microdilution plate assay in which a standard amount of ,-lactamase was reacted with nitrocefin in the presence of various inhibitors and competing substrates (11) . Results are expressed in terms of maximal percent inhibition, which occurred at 2 min or, occasionally, at 5 min. When the maximal inhibition exceeded 25%, the rate of decrease of inhibition (slope) was also calculated from the linear portion of the inhibition curve as follows: (maximum percent inhibition -percent inhibition at 10 min)/10. Comparison enzymes included TEM-1, TEM-2, TEM-101 (6), TEM-5 (13), TEM-6 (2), TEM-7 (6), TEM-9 (21), TEM-10 (16), and CAZ-2 (4). The specific strains and plasmids used have been described in detail elsewhere (11) . Each assay was repeated three to seven times.
DNA techniques. Plasmids were isolated by alkaline lysis techniques (7, 22) , separated by electrophoresis on 0.7% agarose (Sigma), and visualized with UV light after treatment with ethidium bromide.
Restriction digestion was carried out with the restriction endonucleases HindlIl and EcoRI (Boehringer-Mannheim, Indianapolis, Ind.) according to the specifications of the manufacturer.
Plasmid DNA was transferred to nitrocellulose filters by the method of Southern (20) . A 424-bp BglI-HincII fragment of plasmid pBR322, internal to the TEM-1 P-lactamase gene (10) , was labeled with digoxigenin as described by the manufacturer (Boehringer-Mannheim). Hybridization was carried out under conditions of high stringency with detection of label by enzyme-linked immunoassay. Resistant organisms were isolated from sputum (n = 11), urine (n = 8), wound (n = 7), conjunctiva (n = 1), blood (n = 1), and peritoneal dialysate (n = 1). Of the 29 isolates, 16 were cultured in conjunction with significant signs of clinical infection (eight cases of pneumonia, five urinary tract infections, one wound infection, one peritoneal dialysis-associated case of peritonitis, and one case of septicemia). The remaining 13 isolates were judged to be colonizing only. Of 14 infected patients treated with agents that were active against the isolates, all had a favorable clinical response. Antibiotics used to treat these infections included amikacin (n = 4), cefotaxime (n = 4), trimethoprim-sulfamethoxazole (n = 3), and ciprofloxacin (n = 3). The offending organism was absent from subsequent cultures in eight of eight cases for which follow-up cultures were available.
RESULTS
Review of patient location revealed no geographical clustering of cases ( thermosensitive transfer suggest that pMG224 and pMG225 belong to incompatibility group H12 (23) .
The two available E. cloacae strains contained similar transmissible ceftazidime resistance plasmids encoding the same multiresistance pattern as that encoded by pMG224 or pMG225.
,1-Lactamase characterization. The 3-lactamase encoded by pMG224, designated YOU-2, had a pl of 5.2, while that produced by pMG225, termed YOU-1, had a pl of 5.57 (Fig.  2) . The results in Table 2 show that YOU-2 was indistinguishable both in pl and reactions with inhibitors from TEM-101, an enzyme derived in the laboratory from TEM-1 by selection on ceftazidime plates (6) . YOU-1 focused at a pl higher than that of TEM-9 but similar to that of TEM-5 and TEM-10 ( Fig. 2) . However, YOU-1 differed from in that it was poorly inhibited by cefsulodin and was highly inhibited by cefpirome. Additionally, YOU-1 presented a relatively fast decrease in inhibition by aztreonam, cefpirome, and ceftriaxone compared with TEM-10. Indeed, YOU-1 more closely resembled CAZ-2 than TEM-5 or TEM-10 in its inhibition profile but could readily be distinguished from it by isoelectric focusing (Fig. 3) . The spectra of resistance conferred by YOU-1, YOU-2, and several previously described ceftazidime hydrolyzing enzymes are given in Table 3 . Each 3-lactamase enhanced resistance to ceftazidime and aztreonam and, to a lesser degree, to cefotaxime and ceftriaxone, unlike TEM-1 or TEM-2, which could not effectively hydrolyze these substrates. YOU-1 provided a higher level of P-lactam resistance than that provided by YOU-2. The majority of the ceftazidime-resistant isolates available for study (11 of 15 isolates) followed the pattern of K. pneumoniae 5657 and E. coli J53-2(pMG225).
Plasmid analysis. Ceftazidime resistance could be transferred to E. coli J53-2 from 9 of 15 isolates. In each case, resistance to at least chloramphenicol, gentamicin, and tetracycline transferred along with ceftazidime resistance. Transconjugants contained a plasmid of at least 180 kb, but in those derived from strain 5934, the responsible plasmid was slightly smaller.
The clinical isolates themselves showed a variety of plasmid patterns, supporting the impression that the outbreak was not caused by dissemination of a single organism throughout the hospital (Fig. 4) . One isolate (strain 5624) lacked the 180-kb plasmid seen in other strains and was susceptible to chloramphenicol and tetracycline but, nonetheless, elaborated a 1-lactamase with a pl of 5.57 like that encoded by pMG225.
Restriction digestion of plasmids in transconjugants revealed identical patterns in eight of nine isolates, with only pMG224 (derived from strain 5934) showing a different pattern. Figure 5 shows a comparison of pMG225, which represented the most common pattern and encoded YOU-1 P-lactamase, and pMG224, which encoded YOU-2 P-lactamase. Many bands of identical size were seen in the digests of the two plasmids, but there were at least two bands that were unique to pMG224 and one that was unique to pMG225.
With an internal fragment of the TEM-1 P-lactamase gene used as a probe, hybridization to both plasmids under stringent conditions was demonstrated, indicating that both YOU-1 and YOU-2 are encoded by genes that are closely related to the TEM-1 gene. However, after restriction digestion of plasmids pMG224 and pMG225, the hybridizing fragments differed in size (Fig. 5) , lending further support to the concept that the enzymes are encoded by related but distinct plasmids. Included as a control in Fig. 5 is a digest of plasmid pMG223, which was isolated from a patient at the Massachusetts General Hospital in February 1988 (8) . This plasmid also belongs to the H12 incompatibility group and encodes both TEM-1 and an extended-spectrum enzyme with a pl of 5.57 and with an inhibition profile indistinguishable from that of TEM-10, accounting for hybridization to two separate restriction fragments with the TEM-1 probe. DISCUSSION Ceftazidime has gained widespread use by virtue of its substantial activity against a broad spectrum of gram-negative pathogens, including P. aeruginosa. Recent reports, however, have described members of the family Enterobacteriaceae with ,-lactamases that have a high degree of activity against this agent (14) . These isolates have generally occurred sporadically, especially in intensive care wards, and have been reported outside the United States. We described what we believe is the first reported hospital-wide outbreak in the United States of colonization and infection with isolates of Enterobacteriaceae that are highly resistant to ceftazidime.
This outbreak demonstrates the ease with which Enterobacteriaceae can acquire and spread resistance determinants when they are subjected to antibiotic pressure. The development of resistance appears to have followed at least two courses with the production of two separate enzymes that differ in their pIs and in the level of resistance to ,B-lactams. The plasmids encoding these ,B-lactamases, however, are related in that they have similar restriction digests, equivalent resistances to non-4-lactam antibiotics, and identical incompatibility specificities. Furthermore, both novel ,-lactamase genes are related to TEM-1 by DNA hybridization, The frequency with which patients were exposed to ceftazidime prior to the isolation of resistant organisms suggested that the outbreak was related to selective pressure from ceftazidime use. The prolonged lengths of patient stays at the chronic-care facility may also have facilitated emergence of organisms that were repeatedly selected for ceftazidime resistance. Most of the previously reported ceftazidime-resistant members of the family Enterobacteriaceae have been isolated from intensive-care units where prolonged exposure to broad-spectrum cephalosporins was also seen. Study of resistance development at other chronic-care hospitals will be needed to differentiate ceftazidime use from other factors that may contribute to the selection of such resistant pathogens.
It is fortunate that therapeutic alternatives existed in all cases in this outbreak, and each infected patient who was administered an active agent demonstrated a clinical response. There is little comfort to be derived from this success, however, since plasmids carrying the genes for these extended-spectrum enzymes also carried resistance to a variety of other antimicrobial agents. The activity of the extended-spectrum enzymes against most other 1-lactams provides strong selection for their persistence, despite removal of the initial offending agent, a bias demonstrated by the continued isolation of ceftazidime-resistant organisms 7 months after empiric use of this agent was discontinued.
